MSN Labs Introduces Fesobig, A Generic Medication for Urinary Incontinence in India
Fesobig, a bioequivalent generic version of Fesoterodine Fumarate tablet, has been introduced by MSN Labs for the treatment of overactive bladder (OAB) and urinary incontinence (UI). (UI).
“The introduction of Fesobig (Fesoterodine) tablets is consistent with our ongoing commitment to research in bringing affordable medications across critical therapies to alleviate the suffering of Indian patients,” M.S.N. Reddy, Chairman and Managing Director of MSN Group, said on Wednesday.
“We are certain that Fesobig will endow patients with a much more confident way of life by eliminating the social and psychological discomfort associated with the condition,” said Bharat Reddy, Executive Director of MSN Group.
He added that the medication was “affordably” priced at 17 for a 4mg tablet and 27 for an 8 mg tablet.
According to studies, one in every three women over the age of 50 suffers from urinary incontinence, which has a negative effect on their quality of life.